CLINICAL_TRIALS
trial_result
· 2025-06-05
Clinical Trial Update: Comparison of Rimegepant and Placebo for Pain in IBS [Phase 2]
Summary
A Phase 2 trial comparing rimegepant to placebo for pain in irritable bowel syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED